CN115124491A - Preparation method of cyclododecane oxide and cyclododecanone - Google Patents

Preparation method of cyclododecane oxide and cyclododecanone Download PDF

Info

Publication number
CN115124491A
CN115124491A CN202110321836.1A CN202110321836A CN115124491A CN 115124491 A CN115124491 A CN 115124491A CN 202110321836 A CN202110321836 A CN 202110321836A CN 115124491 A CN115124491 A CN 115124491A
Authority
CN
China
Prior art keywords
formula
palladium
reaction
compound
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110321836.1A
Other languages
Chinese (zh)
Inventor
张新刚
闵巧桥
王树华
苏利红
叶立峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Zhejiang Juhua Technology Center Co Ltd
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Zhejiang Juhua Technology Center Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS, Zhejiang Juhua Technology Center Co Ltd filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CN202110321836.1A priority Critical patent/CN115124491A/en
Publication of CN115124491A publication Critical patent/CN115124491A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/18Systems containing only non-condensed rings with a ring being at least seven-membered
    • C07C2601/20Systems containing only non-condensed rings with a ring being at least seven-membered the ring being twelve-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a preparation method of cyclododecane oxide and cyclododecanone. The invention provides a preparation method of epoxy dodecane shown in a formula B, which comprises the following steps: in the presence of a catalyst, carrying out hydrogenation reaction on a compound shown as a formula A as shown in the following formula to obtain a compound shown as a formula B; the catalyst is selected from any one of the following schemes: the first scheme is as follows: the catalyst is a palladium catalyst and an amine compound; scheme two; the catalyst is a palladium complex containing an amine compound. The preparation method of the epoxy dodecane does not generate alcohol byproducts. The epoxy dodecane prepared by the method can be efficiently prepared to obtain high-purity cyclododecanone.

Description

一种环氧十二烷和环十二酮的制备方法A kind of preparation method of epoxy dodecane and cyclododecanone

技术领域technical field

本发明涉及一种环氧十二烷和环十二酮的制备方法。The present invention relates to a preparation method of epoxydodecane and cyclododecanone.

背景技术Background technique

环十二酮及其衍生物砌块在生物医药、农药和材料科学等方面都有着广泛的应用。然而,传统的合成环十二酮的方法中,主要由环十二烷或者环十二醇通过选择性氧化制得(例如,(a)Barton,D.H.R.;Chavasiri,W.Tetrahedron 1994,50,19–30;(b)Balavoinea,D.;Barton,D.H.R.;Boivin,J.;Gref,A.;Ozbalik,N.;Rivière,H.Tetrahedron Letters,1986,27,2849–2852;(c)李俊平等CN 106278814 A 2017-01-04)。但是,这些方法通常选择性差、效率低、能耗高,尤其是由环十二醇氧化制备环十二酮时,产物环十二酮和原料环十二醇性质相近,终产物环十二酮的纯化存在一定的困难,给高纯环十二酮的规模化生产带来很大的挑战。Cyclododecanone and its derivative building blocks are widely used in biomedicine, pesticide and material science. However, in the traditional method of synthesizing cyclododecanone, it is mainly obtained from cyclododecane or cyclododecanol by selective oxidation (eg, (a) Barton, D.H.R.; Chavasiri, W. Tetrahedron 1994, 50, 19 –30; (b) Balavoinea, D.; Barton, D.H.R.; Boivin, J.; Gref, A.; Ozbalik, N.; Rivière, H. Tetrahedron Letters, 1986, 27, 2849–2852; (c) Li Jun Equality CN 106278814 A 2017-01-04). However, these methods usually have poor selectivity, low efficiency and high energy consumption, especially when cyclododecanone is prepared by oxidation of cyclododecanol, the properties of the product cyclododecanone and the raw material cyclododecanol are similar, and the final product cyclododecanone has similar properties. There are certain difficulties in the purification of cyclododecanone, which brings great challenges to the large-scale production of high-purity cyclododecanone.

一些早期的理论研究表明,环氧十二烷可以在金属卤盐的催化下发生重排反应,得到高纯的环十二酮((a)Zakharkin,L.I.,Guseva,V.V.,Kamernitskii,D.A.,Tsvetkov,V.F.,and Likhomanenko,V.A.,Zh.Org.Khim.1990,26,1497;(b)Champalbert,J.,Guillois,A.,Jullien,J.,Jullien,R.,Lai,N.T.,Pascard,C.,and Prange,T.Tetrahedron Lett.1977,20,3251;(c)Wilke,G.and Borner,P.W.,Ger.1075601 1960;(d)Filadska,M.and Balbolov,E.,J.Mol.Catal.1992,73,157.)。这些研究在一定程度上为高纯环十二酮的规模化合成提供了可能。但是,这些方法仍然存在以下两个方面的不足:1.上述文献报道合成环氧十二烷所使用的试剂价格昂贵、条件苛刻、选择性差,并且难以进行规模化生产;2.目前的方法还存在催化剂昂贵、用量高、反应温度高、溶剂用量大等不足,难以适应规模化生产的要求。Some early theoretical studies have shown that dodecane oxide can undergo rearrangement reactions catalyzed by metal halide salts to give high-purity cyclododecanones ((a) Zakharkin, L.I., Guseva, V.V., Kamernitskii, D.A., Tsvetkov , V.F., and Likhomanenko, V.A., Zh.Org.Khim. 1990, 26, 1497; (b) Champalbert, J., Guillois, A., Jullien, J., Jullien, R., Lai, N.T., Pascard, C ., and Prange, T. Tetrahedron Lett. 1977, 20, 3251; (c) Wilke, G. and Borner, P.W., Ger. 1075601 1960; (d) Filadska, M. and Balbolov, E., J. Mol. Catal. 1992, 73, 157.). These studies provide the possibility for the large-scale synthesis of high-purity cyclododecanone to a certain extent. However, these methods still have the following two deficiencies: 1. the above-mentioned literature reports that the reagents used in the synthesis of epoxy dodecane are expensive, harsh conditions, poor selectivity, and difficult to carry out large-scale production; 2. the current method is also There are disadvantages such as expensive catalyst, high dosage, high reaction temperature, large amount of solvent, etc., and it is difficult to meet the requirements of large-scale production.

2001的专利US 2004181096A12,提供了一种铂催化制备环十二酮的方法,该研究表明:制备环氧十二烷的过程中存在的环十二醇杂质(超过2%时)对重排反应的速率和制备环十二酮的纯度影响十分显著,导致重排反应的效率显著下降。该专利中的方案的缺点为:(1)使用了昂贵的贵金属铂催化剂;(2)铂催化剂催化氢化的活性较低,具体为需要使用较高的反应温度(70~140℃)和很高的氢化压力(至少50个大气压),当氢气压力降低时(5至10个大气压),反应体系的选择性明显下降、各类副反应和杂质显著增加。这些杂质不仅会影响重排反应的速度,同时也增加了产物纯化的难度。此外,该专利中重排反应的温度高达200度,能耗高并且对设备要求高。因此,该专利提供的方法尚不适合规模化生产高纯环十二酮,直接应用该技术进行工业化生产还存在很高的技术要求和设备设施的挑战。The patent US 2004181096A12 of 2001 provides a method for preparing cyclododecanone catalyzed by platinum. The research shows that: the cyclododecanol impurities (over 2%) existing in the process of preparing epoxydodecane have a negative effect on the rearrangement reaction The effect on the rate of cyclododecanone and the purity of the prepared cyclododecanone is significant, resulting in a significant decrease in the efficiency of the rearrangement reaction. The disadvantages of the solution in this patent are: (1) expensive noble metal platinum catalysts are used; (2) platinum catalysts have low catalytic hydrogenation activity, specifically, a relatively high reaction temperature (70-140° C.) and high The hydrogenation pressure (at least 50 atmospheres), when the hydrogen pressure is reduced (5 to 10 atmospheres), the selectivity of the reaction system decreases significantly, and various side reactions and impurities increase significantly. These impurities not only affect the speed of the rearrangement reaction, but also increase the difficulty of product purification. In addition, the temperature of the rearrangement reaction in this patent is as high as 200 degrees, the energy consumption is high and the equipment requirements are high. Therefore, the method provided by this patent is not yet suitable for large-scale production of high-purity cyclododecanone, and there are still high technical requirements and challenges in equipment and facilities by directly applying this technology for industrial production.

日本科学家(Sajiki,H.;Hattori,K.;and Hirota,K.Chem.Eur.J.2000,6,2200.)研究了一种钯/碳和乙二胺的络合物选择性催化氢化的9,10-环氧-1,5-环十二碳二烯的方法,该方法以93%的产率制备得到环氧十二烷(97%)和环十二醇(3%)的混合物。注意到其中环十二醇不仅会影响环氧十二烷的重排反应制备高纯环十二酮,也会给环十二酮产物的纯化带来困难。因此,该方法同样不足以支撑高纯环十二酮的合成需求,尤其是大规模化的工业生产。Japanese scientists (Sajiki, H.; Hattori, K.; and Hirota, K.Chem.Eur.J.2000, 6, 2200.) studied the selective catalytic hydrogenation of a complex of palladium/carbon and ethylenediamine The method of 9,10-epoxy-1,5-cyclododecadiene which produces epoxydodecane (97%) and cyclododecane (3%) in 93% yield mixture. It is noted that cyclododecanol will not only affect the rearrangement of epoxydodecane to prepare high-purity cyclododecanone, but also bring difficulties to the purification of cyclododecanone product. Therefore, this method is also insufficient to support the synthetic requirements of high-purity cyclododecanone, especially for large-scale industrial production.

因此,探索一种原料廉价易得,并且合成方法高效简便、催化剂廉价易得且用量低、反应条件温和、适宜于大规模化生产高纯度环十二酮的新方法具有显著的意义。Therefore, it is of great significance to explore a new method with cheap and easy-to-obtain raw materials, efficient and simple synthetic method, cheap and easy-to-obtain catalyst and low dosage, mild reaction conditions, and suitable for large-scale production of high-purity cyclododecanone.

发明内容SUMMARY OF THE INVENTION

本发明所要解决的技术问题在于克服现有技术环十二酮合成过程中,9,10-环氧-1,5环十二碳二烯选择性氢化时易生成环醇副产物、能耗高和三废高等缺点。本发明提供一种环氧十二烷和环十二酮的制备方法。The technical problem to be solved by the present invention is to overcome in the prior art cyclododecanone synthesis process, 9,10-epoxy-1,5 cyclododecadiene is prone to generate cycloalcohol by-products during selective hydrogenation, and the energy consumption is high And three wastes and high disadvantages. The invention provides a preparation method of epoxydodecane and cyclododecanone.

本发明提供一种如式B所示的环氧十二烷的制备方法,其包含如下步骤:在催化剂存在下,如式A所示化合物进行如下式所示的氢化反应得如式B所示化合物;The present invention provides a preparation method of epoxydodecane shown in formula B, which comprises the following steps: in the presence of a catalyst, the compound shown in formula A is subjected to the hydrogenation reaction shown in the following formula to obtain the formula shown in formula B compound;

所述的催化剂选自以下任一方案:Described catalyst is selected from following any scheme:

方案一:所述的催化剂为钯催化剂和胺类化合物;Scheme one: the catalyst is a palladium catalyst and an amine compound;

方案二;所述的催化剂为含胺类化合物的钯络合物;Scheme 2; Described catalyst is the palladium complex containing amine compound;

所述的胺类化合物选自2,2’-联吡啶、“被1、2、3或4个R-1取代的2,2’-联吡啶”和“被1、2、3或4个R-2取代的二胺化合物”中的一种或多种;The amine compound is selected from 2,2'-bipyridine, "2,2'-bipyridine substituted by 1, 2, 3 or 4 R -1 " and "substituted by 1, 2, 3 or 4 R-1" One or more of R -2 substituted diamine compounds";

所述的被1、2、3或4个R-2取代的二胺化合物中,R-2连接在氮原子上;所述的二胺化合物为乙二胺、1,3-丙二胺、1,4-丁二胺或1,2-环己二胺;In the diamine compound substituted by 1, 2, 3 or 4 R -2 , R -2 is connected to the nitrogen atom; the diamine compound is ethylenediamine, 1,3-propanediamine, 1,4-Butanediamine or 1,2-cyclohexanediamine;

各个R-1独立地为C1~C20烷基、卤素、苯基、苄氧基或苯氧基;each R -1 is independently C 1 -C 20 alkyl, halogen, phenyl, benzyloxy or phenoxy;

各个R-2独立地为C1~C20烷基、苯基或苄基;Each R -2 is independently C 1 -C 20 alkyl, phenyl or benzyl;

Figure BDA0002993174910000031
Figure BDA0002993174910000031

所述的方案一中,所述的钯催化剂和所述的胺类化合物分别加入至体系中;所述的方案二中,所述的钯络合物为以本领常规的含钯试剂和所述的胺类化合物为原料形成的络合物。In the scheme one, the palladium catalyst and the amine compound are respectively added to the system; in the scheme two, the palladium complex is a conventional palladium-containing reagent and the The amine compound is the complex formed by the raw material.

所述的氢化反应中,较佳地,R-1中,所述的C1~C20烷基为C1~C9烷基;较佳地,所述的C1~C9烷基为甲基、乙基、正丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、戊基、己基、庚基、辛基或正壬基,例如甲基、乙基或正壬基。In the hydrogenation reaction, preferably, in R -1 , the C 1 -C 20 alkyl group is a C 1 -C 9 alkyl group; preferably, the C 1 -C 9 alkyl group is a C 1 -C 9 alkyl group Methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl or n-nonyl, e.g. methyl, ethyl base or n-nonyl.

所述的氢化反应中,较佳地,R-1中,所述的卤素可为氟、氯、溴或碘。In the hydrogenation reaction, preferably, in R -1 , the halogen can be fluorine, chlorine, bromine or iodine.

所述的氢化反应中,R-2中,所述的C1~C20烷基为C1~C9烷基;较佳地,所述的C1~C9烷基为甲基、乙基、正丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、戊基、己基、庚基、辛基或壬基,例如甲基或乙基。In the hydrogenation reaction, in R -2 , the C 1 -C 20 alkyl group is a C 1 -C 9 alkyl group; preferably, the C 1 -C 9 alkyl group is methyl, ethyl , n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl or nonyl, eg methyl or ethyl.

所述的氢化反应中,较佳地,所述的胺类化合物为2,2’-联吡啶或“被1、或2个R-1取代的2,2’-联吡啶”。In the hydrogenation reaction, preferably, the amine compound is 2,2'-bipyridine or "2,2'-bipyridine substituted by 1 or 2 R -1 ".

所述的氢化反应中,较佳地,各个R-1独立地为C1~C9烷基。In the hydrogenation reaction, preferably, each R -1 is independently a C 1 -C 9 alkyl group.

所述的氢化反应中,较佳地,“被1、2、3或4个R-1取代的2,2’-联吡啶”为被1或2个R-1取代的2,2’-联吡啶。In the hydrogenation reaction, preferably, "2,2'-bipyridine substituted by 1, 2, 3 or 4 R -1 " is 2,2'-bipyridine substituted by 1 or 2 R -1 Bipyridine.

所述的氢化反应中,较佳地,各个R-1相同。In the hydrogenation reaction, preferably, each R -1 is the same.

所述的氢化反应中,较佳地,各个R-2相同。In the hydrogenation reaction, preferably, each R -2 is the same.

所述的氢化反应中,较佳地,各个R-2独立地为C1~C9烷基。In the hydrogenation reaction, preferably, each R -2 is independently a C 1 -C 9 alkyl group.

所述的氢化反应中,较佳地,所述的被2个R-1取代的2,2’-联吡啶为

Figure BDA0002993174910000041
In the hydrogenation reaction, preferably, the 2,2'-bipyridine substituted by 2 R -1 is
Figure BDA0002993174910000041

所述的氢化反应中,较佳地,所述的胺类化合物选自2,2’-联吡啶、“被1、或2个R-1取代的2,2’-联吡啶”和“被1或2个R-2取代的二胺化合物”中的一种或多种;各个R-1为C1~C9烷基或苯基;各个R-2为C1~C20烷基或苄基;更佳地,所述的胺类化合物选自2,2’-联吡啶、N,N'-二甲基-1,2-环己二胺、四甲基乙二胺、N,N-二甲基乙二胺、N,N’-二甲基乙二胺、(R,R)-1,2-二苯基乙二胺、(S,S)-1,2-二苯基乙二胺、(R,S)-1,2-二苯基乙二胺、N,N-二甲基-1,2-环己二胺和

Figure BDA0002993174910000042
中的一种或多种;例如,所述的胺类化合物为2,2’-联吡啶、N,N'-二甲基-1,2-环己二胺、四甲基乙二胺、N,N-二甲基乙二胺、N,N’-二甲基乙二胺或
Figure BDA0002993174910000051
还例如,所述的胺类化合物为2,2’-联吡啶、N,N'-二甲基-1,2-环己二胺、四甲基乙二胺、N,N-二甲基乙二胺或N,N’-二甲基乙二胺。In the hydrogenation reaction, preferably, the amine compound is selected from 2,2'-bipyridine, "2,2'-bipyridine substituted by 1 or 2 R -1 " and "2,2'-bipyridine substituted by 1 or 2 R-1". One or more of 1 or 2 R -2 substituted diamine compounds"; each R -1 is C 1 -C 9 alkyl or phenyl; each R -2 is C 1 -C 20 alkyl or Benzyl; more preferably, the amine compound is selected from 2,2'-bipyridine, N,N'-dimethyl-1,2-cyclohexanediamine, tetramethylethylenediamine, N, N-dimethylethylenediamine, N,N'-dimethylethylenediamine, (R,R)-1,2-diphenylethylenediamine, (S,S)-1,2-diphenyl Ethylenediamine, (R,S)-1,2-diphenylethylenediamine, N,N-dimethyl-1,2-cyclohexanediamine and
Figure BDA0002993174910000042
One or more of; for example, the amine compounds are 2,2'-bipyridine, N,N'-dimethyl-1,2-cyclohexanediamine, tetramethylethylenediamine, N,N-dimethylethylenediamine, N,N'-dimethylethylenediamine or
Figure BDA0002993174910000051
In another example, the amine compounds are 2,2'-bipyridine, N,N'-dimethyl-1,2-cyclohexanediamine, tetramethylethylenediamine, N,N-dimethylamine Ethylenediamine or N,N'-dimethylethylenediamine.

所述的氢化反应中,较佳地,所述的钯催化剂为二价钯催化剂和/或零价钯催化剂;所述的二价钯催化剂优选为Pd(OAc)2、PdBr2、含氯二价钯、Pd(OH)2/C、三氟乙酸钯、二(乙酰丙酮)钯(II)、特戊酸钯、

Figure BDA0002993174910000052
Figure BDA0002993174910000053
中的一种或多种;所述的含氯二价钯优选为二氯二(三环己基瞵)钯、氯化烯丙基钯(II)二聚物、[1,3-双二苯基磷丙烷]氯化钯、1,2-二(二苯基膦基)乙烷二氯化钯(II)、(1,5-环辛二烯)二氯化钯(II)、二氯化钯、PdCl2(dppf)、PdCl2(PPh3)2、PdCl2(Xantphos)、[PdCl(C3H5)]2、PdCl2(MeCN)2或PdCl2(PhCN);所述的零价钯催化剂优选为Pd2(dba)3、Pd(dba)2、Pd2(dba)3.CHCl3、Pd(PPh3)4、Pd(PCy3)2、Pd(COD)2和Pd/C中的一种或多种;更佳地,所述的钯催化剂为Pd(OAc)2、Pd(OH)2/C或含氯二价钯,例如Pd(OH)2/C。In the hydrogenation reaction, preferably, the palladium catalyst is a divalent palladium catalyst and/or a zerovalent palladium catalyst; the divalent palladium catalyst is preferably Pd(OAc) 2 , PdBr 2 , chlorine-containing divalent palladium catalyst Valence palladium, Pd(OH) 2 /C, palladium trifluoroacetate, bis(acetylacetonate) palladium(II), palladium pivalate,
Figure BDA0002993174910000052
Figure BDA0002993174910000053
One or more in; Described chlorine-containing divalent palladium is preferably dichlorobis(tricyclohexyl) palladium, chloride allylpalladium (II) dimer, [1,3-bis-diphenylene] phosphopropane]palladium chloride, 1,2-bis(diphenylphosphino)ethanedichloropalladium(II), (1,5-cyclooctadiene)palladium(II) dichloride, dichloro Palladium, PdCl 2 (dppf), PdCl 2 (PPh 3 ) 2 , PdCl 2 (Xantphos), [PdCl (C 3 H 5 )] 2 , PdCl 2 (MeCN) 2 or PdCl 2 (PhCN); described The zerovalent palladium catalyst is preferably Pd 2 (dba) 3 , Pd(dba) 2 , Pd 2 (dba) 3 .CHCl 3 , Pd(PPh 3 ) 4 , Pd(PCy 3 ) 2 , Pd(COD) 2 and Pd One or more of /C; more preferably, the palladium catalyst is Pd(OAc) 2 , Pd(OH) 2 /C or chlorine-containing divalent palladium, such as Pd(OH) 2 /C.

所述的氢化反应中,较佳地,所述的钯络合物选自

Figure BDA0002993174910000061
In the described hydrogenation reaction, preferably, the palladium complex is selected from
Figure BDA0002993174910000061

Figure BDA0002993174910000062
中的一种或多种。
Figure BDA0002993174910000062
one or more of.

所述的氢化反应中,较佳地,所述的钯催化剂与所述的如式A所示化合物的摩尔比为0.000001~0.99;优选为0.001~0.1,例如0.02、0.01或0.05。In the hydrogenation reaction, preferably, the molar ratio of the palladium catalyst to the compound represented by formula A is 0.000001-0.99; preferably 0.001-0.1, such as 0.02, 0.01 or 0.05.

所述的氢化反应中,较佳地,所述的络合物与所述的如式A所示化合物的摩尔比为0.000001~0.99;优选为0.001~0.1,例如0.02、0.01或0.05。In the hydrogenation reaction, preferably, the molar ratio of the complex to the compound represented by formula A is 0.000001-0.99; preferably 0.001-0.1, such as 0.02, 0.01 or 0.05.

所述的氢化反应中,较佳地,所述的胺类化合物与所述的钯催化剂的摩尔比为(0.1~10):1,优选为(1~3):1,例如1:1或2:1。In the hydrogenation reaction, preferably, the molar ratio of the amine compound to the palladium catalyst is (0.1-10):1, preferably (1-3):1, such as 1:1 or 2:1.

所述的氢化反应中,所述的氢化反应可在无溶剂或有溶剂的存在下进行。较佳地,当所述的氢化反应在溶剂存在下进行反应,所述的如式A所示化合物与所述的溶剂的摩尔体积比为0.01~40mmol/mL;优选为0.2~20mmol/mL;例如1mmol/mL、2mmol/mL、20mmol/mL、0.2mmol/mL、0.25mmol/mL或1.25mmol/mL。In the hydrogenation reaction, the hydrogenation reaction can be carried out without a solvent or in the presence of a solvent. Preferably, when the hydrogenation reaction is carried out in the presence of a solvent, the molar volume ratio of the compound shown in formula A to the solvent is 0.01-40 mmol/mL; preferably 0.2-20 mmol/mL; For example 1 mmol/mL, 2 mmol/mL, 20 mmol/mL, 0.2 mmol/mL, 0.25 mmol/mL or 1.25 mmol/mL.

所述的氢化反应中,当所述的氢化反应在溶剂存在下进行反应,所述的溶剂为本领域此类反应的常规溶剂;较佳地,所述的溶剂为醚类溶剂、芳烃类溶剂、酰胺类溶剂、亚砜类溶剂和水中的一种和多种;所述的醚类溶剂优选为四氢呋喃、2-甲基四氢呋喃、甲基叔丁基醚、乙醚、二甲基乙二醚或1,4-二氧六环;所述的芳烃类溶剂优选为甲苯;所述的酰胺类溶剂优选为N-甲基吡咯烷酮、N,N-二甲基甲酰胺、1,3-二甲基-3,4,5,6-四氢-2-嘧啶酮或N,N-二甲基乙酰胺;所述的亚砜类溶剂优选为二甲亚砜;更佳地,所述的溶剂为四氢呋喃、2-甲基四氢呋喃、甲基叔丁基醚、乙醚、二甲基乙二醚、1,4-二氧六环和甲苯中的一种或多种,例如四氢呋喃。In the described hydrogenation reaction, when the described hydrogenation reaction is carried out in the presence of a solvent, the solvent is a conventional solvent for this type of reaction in the field; preferably, the solvent is an ether solvent, an aromatic hydrocarbon solvent , one or more of amide solvents, sulfoxide solvents and water; the ether solvents are preferably tetrahydrofuran, 2-methyltetrahydrofuran, methyl tert-butyl ether, diethyl ether, dimethyl ethylene glycol or 1,4-dioxane; the aromatic hydrocarbon solvent is preferably toluene; the amide solvent is preferably N-methylpyrrolidone, N,N-dimethylformamide, 1,3-dimethylformamide -3,4,5,6-tetrahydro-2-pyrimidinone or N,N-dimethylacetamide; the sulfoxide solvent is preferably dimethyl sulfoxide; more preferably, the solvent is One or more of tetrahydrofuran, 2-methyltetrahydrofuran, methyl tert-butyl ether, diethyl ether, dimethyl ether, 1,4-dioxane, and toluene, such as tetrahydrofuran.

所述的氢化反应中,所述的氢化反应的反应温度为本领域此类反应的常规反应温度,优选40~100℃,例如50~80℃,还例如50℃或80℃。In the hydrogenation reaction, the reaction temperature of the hydrogenation reaction is the conventional reaction temperature of this type of reaction in the art, preferably 40-100°C, for example 50-80°C, and also for example 50°C or 80°C.

所述的氢化反应中,较佳地,所述的氢化反应在氢气存在下进行,所述氢气的压力为0.001atm~100atm,优选为0.8atm~10atm,例如1atm。In the hydrogenation reaction, preferably, the hydrogenation reaction is carried out in the presence of hydrogen, and the pressure of the hydrogen is 0.001 atm to 100 atm, preferably 0.8 atm to 10 atm, such as 1 atm.

所述的氢化反应中,所述的氢化反应的反应时间与反应规模相关,较佳地,所述的氢化反应的反应时间为24~60h,例如24h、28h、30h、48h或60h。In the hydrogenation reaction, the reaction time of the hydrogenation reaction is related to the reaction scale. Preferably, the reaction time of the hydrogenation reaction is 24-60h, such as 24h, 28h, 30h, 48h or 60h.

本发明还提供一种如式C所示的环十二酮的制备方法,其包含如下步骤:The present invention also provides a kind of preparation method of cyclododecanone shown in formula C, it comprises the steps:

(1)按照如上所述的如式B所示的化合物的制备方法,制得所述的如式B所示的化合物;(1) According to the above-mentioned preparation method of the compound shown in formula B, the compound shown in formula B is prepared;

(2)在金属盐存在下,所述的如式B所示的化合物进行如下所示的重排反应得如式C所示的化合物;(2) in the presence of a metal salt, the compound shown in the formula B carries out the rearrangement reaction shown below to obtain the compound shown in the formula C;

Figure BDA0002993174910000071
Figure BDA0002993174910000071

所述的重排反应中,所述的重排反应的反应条件可为本领域此类反应的常规反应条件。In the rearrangement reaction, the reaction conditions of the rearrangement reaction can be the conventional reaction conditions of this type of reaction in the art.

所述的重排反应中,所述的重排反应可在无溶剂或有溶剂的存在下进行。In the rearrangement reaction, the rearrangement reaction can be carried out in the absence of a solvent or in the presence of a solvent.

所述的重排反应中,较佳地,所述的金属盐为金属卤盐;所述的金属盐优选为LiCl、LiBr、LiI、NaCl、NaBr、NaI、KCl、KBr、KI、MgCl2、MgBr2、MgI2、MgBr2OEt2和MgI2OEt2中的一种或多种;例如LiBr、LiI、NaI、LiBr、MgBr、MgI2或MgBr2OEt2In the rearrangement reaction, preferably, the metal salt is a metal halide salt; the metal salt is preferably LiCl, LiBr, LiI, NaCl, NaBr, NaI, KCl, KBr, KI, MgCl 2 , One or more of MgBr 2 , MgI 2 , MgBr 2 OEt 2 and MgI 2 OEt 2 ; for example LiBr, LiI, NaI, LiBr, MgBr, MgI 2 or MgBr 2 OEt 2 .

所述的重排反应中,较佳地,所述的金属盐与所述的如式B所示化合物的摩尔比为0.0001~0.99;优选为0.001~0.1,例如0.04、0.02或0.05。In the rearrangement reaction, preferably, the molar ratio of the metal salt to the compound represented by formula B is 0.0001-0.99; preferably 0.001-0.1, such as 0.04, 0.02 or 0.05.

所述的重排反应中,所述的重排反应的反应温度为本领域此类反应的常规发应温度,例如100~180℃,还例如140~165℃。In the rearrangement reaction, the reaction temperature of the rearrangement reaction is a conventional reaction temperature of this type of reaction in the art, for example, 100-180°C, and for example, 140-165°C.

所述的重排反应中,在二甘醇二甲醚存在下反应。较佳地,所述的如式B所示化合物与所述的二甘醇二甲醚的摩尔体积比为1~5mmol/L,例如2mmol/L。In the rearrangement reaction, the reaction is carried out in the presence of diglyme. Preferably, the molar volume ratio of the compound represented by formula B to the diglyme is 1-5 mmol/L, for example, 2 mmol/L.

所述的重排反应中,所述的重排反应的反应时间与反应规模相关,较佳地,所述的重排反应的反应时间为4~6h。In the rearrangement reaction, the reaction time of the rearrangement reaction is related to the reaction scale, and preferably, the reaction time of the rearrangement reaction is 4-6h.

在不违背本领域常识的基础上,上述各优选条件,可任意组合,即得本发明各较佳实例。On the basis of not violating common knowledge in the art, the above preferred conditions can be combined arbitrarily to obtain preferred examples of the present invention.

术语“卤素”指氟、氯、溴或碘。The term "halogen" refers to fluorine, chlorine, bromine or iodine.

本发明所用试剂和原料均市售可得。The reagents and raw materials used in the present invention are all commercially available.

本发明的积极进步效果在于:The positive progressive effect of the present invention is:

本发明的制备方法可以通过温和的反应条件由9,10-环氧-1,5-环十二碳二烯氢化制备环十二酮,且两步反应都可以在无溶剂下反应,减少了溶剂的排放量。且由9,10-环氧-1,5-环十二碳二烯氢化制备环氧十二烷的步骤中没有醇类副产物的生成。本发明制备得到的环氧十二烷可以高效的制备得到环十二酮。本发明制得的环十二酮产品在生物医药、农药和材料科学等方面都有着广泛的应用。The preparation method of the present invention can prepare cyclododecanone by hydrogenation of 9,10-epoxy-1,5-cyclododecadiene under mild reaction conditions, and the two-step reactions can be carried out without solvent, reducing the need for Solvent emissions. And no alcohol by-products are generated in the step of preparing epoxydodecane by hydrogenation of 9,10-epoxy-1,5-cyclododecadiene. The epoxydodecane prepared by the present invention can efficiently prepare cyclododecanone. The cyclododecanone product prepared by the invention has wide application in biological medicine, pesticide and material science and the like.

具体实施方式Detailed ways

下面通过实施例的方式进一步说明本发明,但并不因此将本发明限制在所述的实施例范围之中。下列实施例中未注明具体条件的实验方法,按照常规方法和条件,或按照商品说明书选择。The present invention is further described below by way of examples, but the present invention is not limited to the scope of the described examples. The experimental methods that do not specify specific conditions in the following examples are selected according to conventional methods and conditions, or according to the product description.

实施例1Example 1

Figure BDA0002993174910000091
Figure BDA0002993174910000091

使用2,2’-联吡啶(31.2mg,0.2mmol,2mol%),10%的Pd(OH)2/C(280.9mg,0.2mmol,2mol%),原料9,10-环氧-1,5-环十二碳二烯(1.78g,10mmol)和THF(10mL)在50度,1atm氢气氛围下反应24小时,合成得到环氧十二烷(1.82g,产率100%)。反应液过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成。Using 2,2'-bipyridine (31.2 mg, 0.2 mmol, 2 mol%), 10% Pd(OH) 2 /C (280.9 mg, 0.2 mmol, 2 mol%), starting material 9,10-epoxy-1, 5-cyclododecadiene (1.78 g, 10 mmol) and THF (10 mL) were reacted at 50°C under 1 atm hydrogen atmosphere for 24 hours to synthesize dodecane oxide (1.82 g, yield 100%). The reaction solution was filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed.

1H NMR(400MHz,CDCl3)δ2.88-2.68(m,2H),2.14-1.77(m,2H),1.50-0.99(m,18H)。 1 H NMR (400 MHz, CDCl 3 ) δ 2.88-2.68 (m, 2H), 2.14-1.77 (m, 2H), 1.50-0.99 (m, 18H).

实施例2Example 2

Figure BDA0002993174910000092
Figure BDA0002993174910000092

使用2,2’-联吡啶(156mg,1mmol,2mol%),10%的Pd(OH)2/C(1.40g,1mmol,2mol%),原料9,10-环氧-1,5-环十二碳二烯(8.92g,50mmol)和THF(50mL)在50度,1atm氢气氛围下反应28小时,合成得到环氧十二烷(9.1g,产率99.5%)。反应液过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,剩余0.5%未反应的原料9,10-环氧-1,5-环十二碳二烯。Using 2,2'-bipyridine (156 mg, 1 mmol, 2 mol %), 10% Pd(OH) 2 /C (1.40 g, 1 mmol, 2 mol %), starting material 9,10-epoxy-1,5-ring Dodecadiene (8.92 g, 50 mmol) and THF (50 mL) were reacted at 50 degrees under a hydrogen atmosphere of 1 atm for 28 hours to synthesize epoxydodecane (9.1 g, yield 99.5%). The reaction solution was filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examination showed that no cyclododecanol was formed, and 0.5% of unreacted raw material 9,10-epoxy-1,5-cyclododecanol remained. carbadiene.

实施例3Example 3

Figure BDA0002993174910000101
Figure BDA0002993174910000101

使用2,2’-联吡啶(156mg,1mmol,1mol%),10%的Pd(OH)2/C(1.40g,1mmol,1mol%),原料9,10-环氧-1,5-环十二碳二烯(17.83g,100mmol)和THF(50mL)在50度,1atm氢气氛围下反应48小时,合成得到环氧十二烷。反应液过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余25%未反应的原料9,10-环氧-1,5-环十二碳二烯。Using 2,2'-bipyridine (156 mg, 1 mmol, 1 mol %), 10% Pd(OH) 2 /C (1.40 g, 1 mmol, 1 mol %), starting material 9,10-epoxy-1,5-ring Dodecadiene (17.83 g, 100 mmol) and THF (50 mL) were reacted at 50 degrees under a hydrogen atmosphere of 1 atm for 48 hours to synthesize epoxydodecane. The reaction solution was filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining 25% was recovered. The starting material for the reaction is 9,10-epoxy-1,5-cyclododecadiene.

实施例4Example 4

Figure BDA0002993174910000102
Figure BDA0002993174910000102

使用2,2’-联吡啶(156mg,1mmol,1mol%),10%的Pd(OH)2/C(1.40g,1mmol,1mol%),原料9,10-环氧-1,5-环十二碳二烯(17.83g,100mmol)和THF(5mL)在50度,1atm氢气氛围下反应48小时,合成得到环氧十二烷。反应液过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余5%未反应的原料9,10-环氧-1,5-环十二碳二烯。Using 2,2'-bipyridine (156 mg, 1 mmol, 1 mol %), 10% Pd(OH) 2 /C (1.40 g, 1 mmol, 1 mol %), starting material 9,10-epoxy-1,5-ring Dodecadiene (17.83 g, 100 mmol) and THF (5 mL) were reacted at 50°C under 1 atm hydrogen atmosphere for 48 hours to synthesize epoxydodecane. The reaction solution was filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining 5% was recovered. The starting material for the reaction is 9,10-epoxy-1,5-cyclododecadiene.

实施例5Example 5

Figure BDA0002993174910000103
Figure BDA0002993174910000103

使用2,2’-联吡啶(156mg,1mmol,1mol%),10%的Pd(OH)2/C(1.40g,1mmol,1mol%),原料9,10-环氧-1,5-环十二碳二烯(17.83g,100mmol)在50度,1atm氢气氛围下反应30小时,合成得到环氧十二烷(18.2g,99.7%)。反应液THF稀释后过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,剩余0.25%未反应的原料9,10-环氧-1,5-环十二碳二烯。Using 2,2'-bipyridine (156 mg, 1 mmol, 1 mol %), 10% Pd(OH) 2 /C (1.40 g, 1 mmol, 1 mol %), starting material 9,10-epoxy-1,5-ring Dodecadiene (17.83 g, 100 mmol) was reacted at 50°C and 1 atm hydrogen atmosphere for 30 hours to synthesize epoxydodecane (18.2 g, 99.7%). The reaction solution was diluted with THF, filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and 0.25% of the unreacted raw material 9,10-epoxy-1,5- remained. Cyclododecadiene.

实施例6Example 6

Figure BDA0002993174910000111
Figure BDA0002993174910000111

使用N,N'-二甲基-1,2-环己二胺(28.4mg,0.2mmol,2mol%),10%的Pd(OH)2/C(280mg,0.2mmol,2mol%),原料9,10-环氧-1,5-环十二碳二烯(1.78g,10mmol)和THF(10mL)在50度,1atm氢气氛围下反应24小时,合成得到环氧十二烷。反应液过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余15%未反应的原料9,10-环氧-1,5-环十二碳二烯。Using N,N'-dimethyl-1,2-cyclohexanediamine (28.4 mg, 0.2 mmol, 2 mol%), 10% Pd(OH) 2 /C (280 mg, 0.2 mmol, 2 mol%), starting material 9,10-Epoxy-1,5-cyclododecadiene (1.78 g, 10 mmol) and THF (10 mL) were reacted at 50 degrees under a hydrogen atmosphere of 1 atm for 24 hours to synthesize epoxydodecane. The reaction solution was filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining 15% was recovered. The starting material for the reaction is 9,10-epoxy-1,5-cyclododecadiene.

实施例7Example 7

Figure BDA0002993174910000112
Figure BDA0002993174910000112

使用四甲基乙二胺(23.2mg,0.2mmol,2mol%),10%的Pd(OH)2/C(280mg,0.2mmol,2mol%),原料9,10-环氧-1,5-环十二碳二烯(1.78g,10.0mmol)和THF(50mL)在50度,1atm氢气氛围下反应24小时,合成得到环氧十二烷。反应液过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余25%未反应的原料9,10-环氧-1,5-环十二碳二烯.Using tetramethylethylenediamine (23.2mg, 0.2mmol, 2mol%), 10% Pd(OH) 2 /C (280mg, 0.2mmol, 2mol%), starting material 9,10-epoxy-1,5- Cyclododecadiene (1.78 g, 10.0 mmol) and THF (50 mL) were reacted at 50°C under 1 atm hydrogen atmosphere for 24 hours to synthesize epoxydodecane. The reaction solution was filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining 25% was recovered. The starting material for the reaction is 9,10-epoxy-1,5-cyclododecadiene.

实施例8Example 8

Figure BDA0002993174910000121
Figure BDA0002993174910000121

使用N,N-二甲基乙二胺(17.6mg,0.2mmol,2mol%),10%的Pd(OH)2/C(280mg,0.12mmol,2mol%),原料9,10-环氧-1,5-环十二碳二烯(1.78g,10mmol)和THF(50mL)在50度,1atm氢气氛围下反应24小时,合成得到环氧十二烷。反应液过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余35%未反应的原料9,10-环氧-1,5-环十二碳二烯。Using N,N-dimethylethylenediamine (17.6mg, 0.2mmol, 2mol%), 10% Pd(OH) 2 /C (280mg, 0.12mmol, 2mol%), starting material 9,10-epoxy- 1,5-Cyclododecadiene (1.78 g, 10 mmol) and THF (50 mL) were reacted at 50 degrees under a hydrogen atmosphere of 1 atm for 24 hours to synthesize epoxydodecane. The reaction solution was filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examination showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining 35% was recovered. The starting material for the reaction is 9,10-epoxy-1,5-cyclododecadiene.

实施例9Example 9

Figure BDA0002993174910000122
Figure BDA0002993174910000122

使用N,N’-二甲基乙二胺(17.6mg,0.2mmol,2mol%),10%的Pd(OH)2/C(280mg,0.2mmol,2mol%),原料9,10-环氧-1,5-环十二碳二烯(1.78g,10mmol)和THF(50mL)在50度,1atm氢气氛围下反应24小时,合成得到环氧十二烷。反应液过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余37%未反应的原料9,10-环氧-1,5-环十二碳二烯。Using N,N'-dimethylethylenediamine (17.6mg, 0.2mmol, 2mol%), 10% Pd(OH) 2 /C (280mg, 0.2mmol, 2mol%), raw material 9,10-epoxy -1,5-cyclododecadiene (1.78 g, 10 mmol) and THF (50 mL) were reacted at 50 degrees and 1 atm hydrogen atmosphere for 24 hours to synthesize epoxydodecane. The reaction solution was filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining 37% was recovered. The starting material for the reaction is 9,10-epoxy-1,5-cyclododecadiene.

实施例10Example 10

Figure BDA0002993174910000123
Figure BDA0002993174910000123

使用2,2’-联吡啶(156mg,1mmol,1mol%),10%的Pd(OH)2/C(1.40g,1mmol,1mol%),原料9,10-环氧-1,5-环十二碳二烯(17.83g,100mmol)在80度,1atm氢气氛围下反应30小时,合成得到环氧十二烷(18.2g,99.7%)。反应液THF稀释后过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,剩余0.25%未反应的原料9,10-环氧-1,5-环十二碳二烯。Using 2,2'-bipyridine (156 mg, 1 mmol, 1 mol %), 10% Pd(OH) 2 /C (1.40 g, 1 mmol, 1 mol %), starting material 9,10-epoxy-1,5-ring Dodecadiene (17.83 g, 100 mmol) was reacted at 80 degrees under a hydrogen atmosphere of 1 atm for 30 hours to synthesize epoxydodecane (18.2 g, 99.7%). The reaction solution was diluted with THF, filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and 0.25% of the unreacted raw material 9,10-epoxy-1,5- remained. Cyclododecadiene.

实施例11Example 11

Figure BDA0002993174910000131
Figure BDA0002993174910000131

使用上述络合物为催化剂(293mg,0.5mmol,1mol%),原料9,10-环氧-1,5-环十二碳二烯(8.92g,50mmol),40mL THF,在50度,1atm氢气氛围下反应60小时,合成得到环氧十二烷(9.1g,99%)。反应液THF稀释后过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,剩余1%未反应的原料9,10-环氧-1,5-环十二碳二烯。Use the above-mentioned complex as catalyst (293mg, 0.5mmol, 1mol%), raw material 9,10-epoxy-1,5-cyclododecadiene (8.92g, 50mmol), 40mL THF, at 50 degrees, 1atm The reaction was carried out under a hydrogen atmosphere for 60 hours to synthesize epoxydodecane (9.1 g, 99%). The reaction solution was diluted with THF, filtered, and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and 1% of unreacted raw materials remained 9,10-epoxy-1,5- Cyclododecadiene.

实施例12Example 12

Figure BDA0002993174910000132
Figure BDA0002993174910000132

使用上述络合物为催化剂(159mg,0.5mmol,5mol%),原料9,10-环氧-1,5-环十二碳二烯(1.78g,10mmol),40mL THF,在50度,1atm氢气氛围下反应60小时,合成得到环氧十二烷(1.72g,94%)。反应液THF稀释后过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余6%未反应的原料9,10-环氧-1,5-环十二碳二烯。Use the above-mentioned complex as catalyst (159mg, 0.5mmol, 5mol%), raw material 9,10-epoxy-1,5-cyclododecadiene (1.78g, 10mmol), 40mL THF, at 50 degrees, 1atm The reaction was carried out under a hydrogen atmosphere for 60 hours to synthesize epoxydodecane (1.72 g, 94%). The reaction solution was diluted with THF, filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining residue was recovered. 6% unreacted starting 9,10-epoxy-1,5-cyclododecadiene.

实施例13Example 13

Figure BDA0002993174910000141
Figure BDA0002993174910000141

使用上述钯的络合物(190mg,0.5mmol,2mol%),原料9,10-环氧-1,5-环十二碳二烯(4.46g,25mmol),THF 20mL在50度,1atm氢气氛围下反应40小时,合成得到环氧十二烷(4.51g,99%)。反应液THF稀释后过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,剩余1%未反应的原料9,10-环氧-1,5-环十二碳二烯。Using the above palladium complex (190mg, 0.5mmol, 2mol%), starting material 9,10-epoxy-1,5-cyclododecadiene (4.46g, 25mmol), THF 20mL at 50 degrees, 1 atm hydrogen The reaction was carried out under the atmosphere for 40 hours to synthesize epoxydodecane (4.51 g, 99%). The reaction solution was diluted with THF, filtered, and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and 1% of unreacted raw materials remained 9,10-epoxy-1,5- Cyclododecadiene.

实施例14Example 14

Figure BDA0002993174910000142
Figure BDA0002993174910000142

使用上述络合物为催化剂(132mg,0.5mmol,5mol%),原料9,10-环氧-1,5-环十二碳二烯(1.78g,10mmol),40mL THF,在50度,1atm氢气氛围下反应60小时,合成得到环氧十二烷(1.65g,90%)。反应液THF稀释后过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余10%未反应的原料9,10-环氧-1,5-环十二碳二烯。Use the above-mentioned complex as catalyst (132mg, 0.5mmol, 5mol%), raw material 9,10-epoxy-1,5-cyclododecadiene (1.78g, 10mmol), 40mL THF, at 50 degrees, 1atm The reaction was carried out under a hydrogen atmosphere for 60 hours to synthesize epoxydodecane (1.65 g, 90%). The reaction solution was diluted with THF, filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining residue was recovered. 10% unreacted starting 9,10-epoxy-1,5-cyclododecadiene.

实施例15Example 15

Figure BDA0002993174910000151
Figure BDA0002993174910000151

使用上述络合物为催化剂(183mg,0.5mmol,5mol%),原料9,10-环氧-1,5-环十二碳二烯(1.78g,10mmol),40mL THF,在50度,1atm氢气氛围下反应60小时,合成得到环氧十二烷(1.49g,81%)。反应液THF稀释后过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余19%未反应的原料9,10-环氧-1,5-环十二碳二烯。Use the above-mentioned complex as catalyst (183mg, 0.5mmol, 5mol%), raw material 9,10-epoxy-1,5-cyclododecadiene (1.78g, 10mmol), 40mL THF, at 50 degrees, 1atm The reaction was carried out under a hydrogen atmosphere for 60 hours to synthesize epoxydodecane (1.49 g, 81%). The reaction solution was diluted with THF, filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining residue was recovered. 19% unreacted starting 9,10-epoxy-1,5-cyclododecadiene.

实施例16Example 16

Figure BDA0002993174910000152
Figure BDA0002993174910000152

使用上述络合物为催化剂(213mg,0.5mmol,5mol%),原料9,10-环氧-1,5-环十二碳二烯(1.78g,10mmol),40mL THF,在50度,1atm氢气氛围下反应60小时,合成得到环氧十二烷(1.47g,80%)。反应液THF稀释后过滤后浓缩得到产物,为无色透明的液体,核磁和GC-MS检查显示无环十二醇形成,其中环氧十二烷的转化产率为>99%,并回收剩余20%未反应的原料9,10-环氧-1,5-环十二碳二烯。Use the above-mentioned complex as catalyst (213mg, 0.5mmol, 5mol%), raw material 9,10-epoxy-1,5-cyclododecadiene (1.78g, 10mmol), 40mL THF, at 50 degrees, 1atm The reaction was carried out under a hydrogen atmosphere for 60 hours to synthesize epoxydodecane (1.47 g, 80%). The reaction solution was diluted with THF, filtered and concentrated to obtain the product, which was a colorless and transparent liquid. NMR and GC-MS examinations showed that no cyclododecanol was formed, and the conversion yield of epoxydodecane was >99%, and the remaining residue was recovered. 20% unreacted starting 9,10-epoxy-1,5-cyclododecadiene.

实施例17Example 17

Figure BDA0002993174910000161
Figure BDA0002993174910000161

氮气保护下,使用LiI(268mg,2mmol,4mol%),和环氧十二烷(9.11g,50mmol,1.0当量),加热至165度反应6小时合成得到环十二酮。二氯甲烷稀释过滤掉碘化锂盐,得到9.11克纯品,产物产率99.9%,产物为白色固体,其熔点为61-63℃。1H NMR(400MHz,CDCl3)δ2.45-2.42(m,4H),1.69-1.66(m,4H),1.28(m,14H)。13C NMR(100MHz,CDCl3)δ213.0,40.3,24.6,24.5,24.2,22.5,22.3。Under nitrogen protection, using LiI (268 mg, 2 mmol, 4 mol%), and epoxydodecane (9.11 g, 50 mmol, 1.0 equiv), heated to 165 degrees and reacted for 6 hours to synthesize cyclododecanone. Dichloromethane was diluted and filtered to remove the lithium iodide salt to obtain 9.11 g of pure product with a yield of 99.9%. The product was a white solid with a melting point of 61-63°C. 1 H NMR (400 MHz, CDCl 3 ) δ 2.45-2.42 (m, 4H), 1.69-1.66 (m, 4H), 1.28 (m, 14H). 13 C NMR (100 MHz, CDCl 3 ) δ 213.0, 40.3, 24.6, 24.5, 24.2, 22.5, 22.3.

实施例18Example 18

Figure BDA0002993174910000162
Figure BDA0002993174910000162

氮气保护下,使用LiI(134mg,1mmol,2mol%),和环氧十二烷(9.11g,50mmol,1.0当量),加热至165度反应6小时合成得到环十二酮。通过硅胶柱柱层析纯化得到8.2克纯品,同时回收原料0.91克,产物产率90%,产物为白色固体,其熔点为60-62℃。Under nitrogen protection, using LiI (134 mg, 1 mmol, 2 mol%), and epoxydodecane (9.11 g, 50 mmol, 1.0 equiv), heated to 165 degrees and reacted for 6 hours to synthesize cyclododecanone. Purified by silica gel column chromatography to obtain 8.2 g of pure product, 0.91 g of raw material was recovered at the same time, the product yield was 90%, and the product was a white solid with a melting point of 60-62°C.

实施例19Example 19

Figure BDA0002993174910000163
Figure BDA0002993174910000163

氮气保护下,使用LiI(134mg,1mmol,5mol%),二甘醇二甲醚(10mL)和环氧十二烷(3.64g,20mmol,1.0当量),加热至140度反应4小时合成得到环十二酮。通过硅胶柱柱层析纯化得到3.27克纯品,产物产率90%,产物为白色固体,其熔点为59-60℃。Under nitrogen protection, use LiI (134 mg, 1 mmol, 5 mol%), diglyme (10 mL) and epoxy dodecane (3.64 g, 20 mmol, 1.0 equiv), heat to 140 degrees and react for 4 hours to synthesize a ring. Dodecone. Purified by silica gel column chromatography to obtain 3.27 g of pure product with a product yield of 90%, the product is a white solid with a melting point of 59-60°C.

实施例20Example 20

Figure BDA0002993174910000171
Figure BDA0002993174910000171

氮气保护下,使用LiBr(87mg,1mmol,5mol%),二甘醇二甲醚(10mL)和环氧十二烷(3.64g,20mmol,1.0当量),加热至140度反应4小时合成得到环十二酮。通过硅胶柱柱层析纯化得到3.0克纯品,产物产率82%,产物为白色固体,其熔点为59-60℃。Under nitrogen protection, using LiBr (87 mg, 1 mmol, 5 mol%), diglyme (10 mL) and dodecane oxide (3.64 g, 20 mmol, 1.0 equiv), heated to 140 degrees and reacted for 4 hours to synthesize a ring Dodecone. Purified by silica gel column chromatography to obtain 3.0 g of pure product, the product yield is 82%, and the product is a white solid with a melting point of 59-60°C.

实施例21Example 21

Figure BDA0002993174910000172
Figure BDA0002993174910000172

氮气保护下,使用NaI(150mg,1mmol,5mol%),二甘醇二甲醚(10mL)和环氧十二烷(3.64g,20mmol,1.0当量),加热至140度反应4小时合成得到环十二酮。通过硅胶柱柱层析纯化得到2.84克纯品,产物产率78%,产物为白色固体,其熔点为59-60℃。Under nitrogen protection, use NaI (150 mg, 1 mmol, 5 mol%), diglyme (10 mL) and epoxydodecane (3.64 g, 20 mmol, 1.0 equiv), heat to 140 degrees and react for 4 hours to synthesize a ring. Dodecone. Purified by silica gel column chromatography to obtain 2.84 g of pure product, the product yield is 78%, and the product is a white solid with a melting point of 59-60°C.

实施例22Example 22

Figure BDA0002993174910000181
Figure BDA0002993174910000181

氮气保护下,使用MgBr2(184mg,1mmol,5mol%),二甘醇二甲醚(10mL)和环氧十二烷(3.64g,20mmol,1.0当量),加热至140度反应4小时合成得到环十二酮。通过硅胶柱柱层析纯化得到2.73克纯品,产物产率75%,产物为白色固体,其熔点为59-60℃。Under nitrogen protection, use MgBr 2 (184 mg, 1 mmol, 5 mol%), diglyme (10 mL) and epoxydodecane (3.64 g, 20 mmol, 1.0 equiv), heat to 140 degrees and react for 4 hours to obtain Cyclododecone. Purified by silica gel column chromatography to obtain 2.73 g of pure product, the product yield is 75%, and the product is a white solid with a melting point of 59-60°C.

实施例23Example 23

Figure BDA0002993174910000182
Figure BDA0002993174910000182

氮气保护下,使用MgI2(278mg,1mmol,5mol%),二甘醇二甲醚(10mL)和环氧十二烷(3.64g,20mmol,1.0当量),加热至140度反应4小时合成得到环十二酮。通过硅胶柱柱层析纯化得到3.20克纯品,产物产率88%,产物为白色固体,其熔点为59-60℃。Under nitrogen protection, use MgI 2 (278 mg, 1 mmol, 5 mol%), diglyme (10 mL) and epoxy dodecane (3.64 g, 20 mmol, 1.0 equiv), heat to 140 degrees and react for 4 hours to obtain Cyclododecone. Purified by silica gel column chromatography to obtain 3.20 g of pure product, the product yield is 88%, and the product is a white solid with a melting point of 59-60°C.

实施例24Example 24

Figure BDA0002993174910000183
Figure BDA0002993174910000183

氮气保护下,使用MgBr2.Et2O(258mg,1mmol,5mol%),二甘醇二甲醚(10mL)和环氧十二烷(3.64g,20mmol,1.0当量),加热至140度反应4小时合成得到环十二酮。通过硅胶柱柱层析纯化得到3.35克纯品,产物产率92%,产物为白色固体,其熔点为59-60℃。Under nitrogen protection, use MgBr 2 .Et 2 O (258 mg, 1 mmol, 5 mol%), diglyme (10 mL) and dodecane oxide (3.64 g, 20 mmol, 1.0 equiv), and heat to 140 degrees to react The cyclododecanone was synthesized in 4 hours. Purified by silica gel column chromatography to obtain 3.35 g of pure product, the product yield is 92%, and the product is a white solid with a melting point of 59-60°C.

在本发明提及的所有文献都在本申请中引用作为参考,就如同每一篇文献被单独引用作为参考那样。此外应理解,在阅读了本发明的上述讲授内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。All documents mentioned herein are incorporated by reference in this application as if each document were individually incorporated by reference. In addition, it should be understood that after reading the above teaching content of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.

Claims (10)

1.一种如式B所示的环氧十二烷的制备方法,其特征在于,其包含如下步骤:在催化剂存在下,如式A所示化合物进行如下式所示的氢化反应得如式B所示化合物;1. a preparation method of epoxy dodecane as shown in formula B, is characterized in that, it comprises the steps: in the presence of a catalyst, compound as shown in formula A carries out the hydrogenation reaction shown in the following formula to obtain as formula The compound shown in B; 所述的催化剂选自以下任一方案:Described catalyst is selected from following any scheme: 方案一:所述的催化剂为钯催化剂和胺类化合物;Scheme one: the catalyst is a palladium catalyst and an amine compound; 方案二;所述的催化剂为含胺类化合物的钯络合物;Scheme 2; Described catalyst is the palladium complex containing amine compound; 所述的胺类化合物选自2,2’-联吡啶、“被1、2、3或4个R-1取代的2,2’-联吡啶”和“被1、2、3或4个R-2取代的二胺化合物”中的一种或多种;The amine compound is selected from 2,2'-bipyridine, "2,2'-bipyridine substituted by 1, 2, 3 or 4 R -1 " and "substituted by 1, 2, 3 or 4 R-1" One or more of R -2 substituted diamine compounds"; 所述的被1、2、3或4个R-2取代的二胺化合物中,R-2连接在氮原子上;所述的二胺化合物为乙二胺、1,3-丙二胺、1,4-丁二胺或1,2-环己二胺;In the diamine compound substituted by 1, 2, 3 or 4 R -2 , R -2 is connected to the nitrogen atom; the diamine compound is ethylenediamine, 1,3-propanediamine, 1,4-Butanediamine or 1,2-cyclohexanediamine; 各个R-1独立地为C1~C20烷基、卤素、苯基、苄氧基或苯氧基;each R -1 is independently C 1 -C 20 alkyl, halogen, phenyl, benzyloxy or phenoxy; 各个R-2独立地为C1~C20烷基、苯基或苄基;Each R -2 is independently C 1 -C 20 alkyl, phenyl or benzyl;
Figure FDA0002993174900000011
Figure FDA0002993174900000011
2.如权利要求1所述的如式B所示的环氧十二烷的制备方法,其特征在于,R-1中,所述的C1~C20烷基为C1~C9烷基;较佳地,所述的C1~C9烷基为甲基、乙基、正丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、戊基、己基、庚基、辛基或壬基,例如甲基、乙基或正壬基;2 . The preparation method of dodecane oxide represented by formula B according to claim 1 , wherein, in R -1 , the C 1 -C 20 alkyl group is a C 1 -C 9 alkane. 3 . Preferably, the C 1 -C 9 alkyl group is methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, Hexyl, heptyl, octyl or nonyl, for example methyl, ethyl or n-nonyl; 和/或,R-1中,所述的卤素为氟、氯、溴或碘;And/or, in R -1 , the halogen is fluorine, chlorine, bromine or iodine; 和/或,R-2中,所述的C1~C20烷基为C1~C9烷基;较佳地,所述的C1~C9烷基为甲基、乙基、正丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、戊基、己基、庚基、辛基或壬基,例如甲基或乙基;And/or, in R -2 , the C 1 -C 20 alkyl group is a C 1 -C 9 alkyl group; preferably, the C 1 -C 9 alkyl group is methyl, ethyl, n- propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl or nonyl, for example methyl or ethyl; 和/或,所述的“被1、2、3或4个R-1取代的2,2’-联吡啶”为被1或2个R-1取代的2,2’-联吡啶;And/or, the "2,2'-bipyridine substituted by 1, 2, 3 or 4 R -1 " is 2,2'-bipyridine substituted by 1 or 2 R -1 ; 和/或,所述的钯催化剂为二价钯催化剂和/或零价钯催化剂。And/or, the palladium catalyst is a divalent palladium catalyst and/or a zerovalent palladium catalyst. 3.如权利要求2所述的如式B所示的环氧十二烷的制备方法,其特征在于,所述的氢化反应中,各个R-1相同;3. the preparation method of epoxy dodecane shown in formula B as claimed in claim 2, is characterized in that, in described hydrogenation reaction, each R -1 is identical; 和/或,各个R-2相同;and/or, each R -2 is the same; 和/或,各个R-2独立地为C1~C9烷基;and/or, each R -2 is independently C 1 -C 9 alkyl; 和/或,各个R-1独立地为C1~C9烷基;and/or, each R -1 is independently C 1 -C 9 alkyl; 和/或,所述的被2个R-1取代的2,2’-联吡啶为
Figure FDA0002993174900000021
And/or, the 2,2'-bipyridine substituted by 2 R -1 is
Figure FDA0002993174900000021
和/或,所述的二价钯催化剂为Pd(OAc)2、PdBr2、含氯二价钯、Pd(OH)2/C、三氟乙酸钯、二(乙酰丙酮)钯、特戊酸钯、
Figure FDA0002993174900000022
中的一种或多种;
And/or, the divalent palladium catalyst is Pd(OAc) 2 , PdBr 2 , chlorine-containing divalent palladium, Pd(OH) 2 /C, palladium trifluoroacetate, bis(acetylacetonate) palladium, pivalic acid palladium,
Figure FDA0002993174900000022
one or more of;
和/或,所述的零价钯催化剂为Pd2(dba)3、Pd(dba)2、Pd2(dba)3.CHCl3、Pd(PPh3)4、Pd(PCy3)2、Pd(COD)2和Pd/C中的一种或多种。And/or, the zero-valent palladium catalyst is Pd 2 (dba) 3 , Pd(dba) 2 , Pd 2 (dba) 3 .CHCl 3 , Pd(PPh 3 ) 4 , Pd(PCy 3 ) 2 , Pd One or more of (COD) 2 and Pd/C.
4.如权利要求3所述的如式B所示的环氧十二烷的制备方法,其特征在于,所述的胺类化合物为2,2’-联吡啶或“被1、或2个R-1取代的2,2’-联吡啶”;4. the preparation method of epoxydodecane shown in formula B as claimed in claim 3, is characterized in that, described amine compound is 2,2'-bipyridine or "by 1, or 2 R -1 substituted 2,2'-bipyridine"; 和/或,所述的含氯二价钯为二氯二(三环己基瞵)钯、氯化烯丙基钯(II)二聚物、[1,3-双二苯基磷丙烷]氯化钯、1,2-二(二苯基膦基)乙烷二氯化钯(II)、(1,5-环辛二烯)二氯化钯(II)、二氯化钯、PdCl2(dppf)、PdCl2(PPh3)2、PdCl2(Xantphos)、[PdCl(C3H5)]2、PdCl2(MeCN)2或PdCl2(PhCN)。And/or, the described chlorine-containing divalent palladium is dichlorodi(tricyclohexyl) palladium, allyl palladium(II) chloride dimer, [1,3-bisdiphenylphosphorane] chlorine Palladium, 1,2-bis(diphenylphosphino)ethanedichloride palladium(II), (1,5-cyclooctadiene)dichloride palladium(II), palladium dichloride, PdCl 2 (dppf), PdCl2 ( PPh3 ) 2 , PdCl2 (Xantphos), [PdCl( C3H5 )] 2 , PdCl2 (MeCN) 2 or PdCl2 ( PhCN). 5.如权利要求3所述的如式B所示的环氧十二烷的制备方法,其特征在于,所述的胺类化合物选自2,2’-联吡啶、“被1、或2个R-1取代的2,2’-联吡啶”和“被1或2个R-2取代的二胺化合物”中的一种或多种;各个R-1为C1~C9烷基或苯基;各个R-2为C1~C20烷基或苄基;较佳地,所述的胺类化合物选自2,2’-联吡啶、N,N'-二甲基-1,2-环己二胺、四甲基乙二胺、N,N-二甲基乙二胺、N,N’-二甲基乙二胺、(R,R)-1,2-二苯基乙二胺、(S,S)-1,2-二苯基乙二胺、(R,S)-1,2-二苯基乙二胺、N,N-二甲基-1,2-环己二胺和
Figure FDA0002993174900000031
中的一种或多种;更佳地,所述的胺类化合物为2,2’-联吡啶、N,N'-二甲基-1,2-环己二胺、四甲基乙二胺、N,N-二甲基乙二胺、N,N’-二甲基乙二胺或
Figure FDA0002993174900000032
还佳地,所述的胺类化合物为2,2’-联吡啶、N,N'-二甲基-1,2-环己二胺、四甲基乙二胺、N,N-二甲基乙二胺或N,N’-二甲基乙二胺;
5. the preparation method of epoxy dodecane shown in formula B as claimed in claim 3, is characterized in that, described amine compound is selected from 2,2'-bipyridine, "by 1, or 2 One or more of "2,2'-bipyridine substituted with 1 R -1 " and "diamine compound substituted with 1 or 2 R -2 "; each R -1 is C 1 -C 9 alkyl or phenyl; each R -2 is C 1 -C 20 alkyl or benzyl; preferably, the amine compound is selected from 2,2'-bipyridine, N,N'-dimethyl-1 ,2-cyclohexanediamine, tetramethylethylenediamine, N,N-dimethylethylenediamine, N,N'-dimethylethylenediamine, (R,R)-1,2-diphenyl Ethylenediamine, (S,S)-1,2-diphenylethylenediamine, (R,S)-1,2-diphenylethylenediamine, N,N-dimethyl-1,2 - cyclohexanediamine and
Figure FDA0002993174900000031
one or more of; more preferably, the amine compound is 2,2'-bipyridine, N,N'-dimethyl-1,2-cyclohexanediamine, tetramethylethylenediamine Amine, N,N-dimethylethylenediamine, N,N'-dimethylethylenediamine or
Figure FDA0002993174900000032
Also preferably, the amine compounds are 2,2'-bipyridine, N,N'-dimethyl-1,2-cyclohexanediamine, tetramethylethylenediamine, N,N-dimethylamine Ethylenediamine or N,N'-dimethylethylenediamine;
和/或,所述的钯络合物选自
Figure FDA0002993174900000033
Figure FDA0002993174900000041
中的一种或多种;
And/or, described palladium complex is selected from
Figure FDA0002993174900000033
Figure FDA0002993174900000041
one or more of;
和/或,所述的钯催化剂为Pd(OAc)2、Pd(OH)2/C或含氯二价钯,例如Pd(OH)2/C。And/or, the palladium catalyst is Pd(OAc) 2 , Pd(OH) 2 /C or chlorine-containing divalent palladium, such as Pd(OH) 2 /C.
6.如权利要求1所述的如式B所示的环氧十二烷的制备方法,其特征在于,所述的钯催化剂与所述的如式A所示化合物的摩尔比为0.000001~0.99;优选为0.001~0.1,例如0.02、0.01或0.05;6. The preparation method of epoxydodecane shown in formula B as claimed in claim 1, wherein the molar ratio of the palladium catalyst to the compound shown in formula A is 0.000001~0.99 ; preferably 0.001 to 0.1, such as 0.02, 0.01 or 0.05; 和/或,所述的络合物与所述的如式A所示化合物的摩尔比为0.000001~0.99;优选为0.001~0.1,例如0.02、0.01或0.05;And/or, the molar ratio of the complex compound to the compound represented by formula A is 0.000001-0.99; preferably 0.001-0.1, such as 0.02, 0.01 or 0.05; 和/或,所述的胺类化合物与所述的钯催化剂的摩尔比为(0.1~10):1,优选为(1~3):1,例如1:1或2:1;And/or, the molar ratio of the amine compound to the palladium catalyst is (0.1-10):1, preferably (1-3):1, such as 1:1 or 2:1; 和/或,所述的氢化反应在无溶剂或有溶剂的存在下进行;And/or, described hydrogenation is carried out in the presence of solvent-free or solvent; 和/或,所述的氢化反应的反应温度为40~100℃,例如50~80℃,还例如50℃或80℃;And/or, the reaction temperature of the hydrogenation reaction is 40 to 100°C, for example, 50 to 80°C, and also for example, 50°C or 80°C; 和/或,所述的氢化反应在氢气存在下进行;所述氢气的压力为0.001atm~100atm,优选为0.8atm~10atm,例如1atm;And/or, the hydrogenation reaction is carried out in the presence of hydrogen; the pressure of the hydrogen is 0.001 atm to 100 atm, preferably 0.8 atm to 10 atm, such as 1 atm; 和/或,所述的氢化反应的反应时间与反应规模相关,较佳地,所述的氢化反应的反应时间为24~60h,例如24h、28h、30h、48h或60h。And/or, the reaction time of the hydrogenation reaction is related to the reaction scale, preferably, the reaction time of the hydrogenation reaction is 24-60h, for example, 24h, 28h, 30h, 48h or 60h. 7.如权利要求6所述的如式B所示的环氧十二烷的制备方法,其特征在于,当所述的氢化反应在溶剂存在下进行反应,所述的如式A所示化合物与所述的溶剂的摩尔体积比为0.01~40mmol/mL;优选为0.2~20mmol/mL;例如1mmol/mL、2mmol/mL、20mmol/mL、0.2mmol/mL、0.25mmol/mL或1.25mmol/mL;7. the preparation method of epoxydodecane shown in formula B as claimed in claim 6, is characterized in that, when described hydrogenation is reacted in the presence of solvent, described compound shown in formula A The molar volume ratio with the solvent is 0.01~40mmol/mL; preferably 0.2~20mmol/mL; for example 1mmol/mL, 2mmol/mL, 20mmol/mL, 0.2mmol/mL, 0.25mmol/mL or 1.25mmol/mL mL; 和/或,当所述的氢化反应在溶剂存在下进行反应;所述的溶剂为醚类溶剂、芳烃类溶剂、酰胺类溶剂、亚砜类溶剂和水中的一种和多种;所述的醚类溶剂优选为四氢呋喃、2-甲基四氢呋喃、甲基叔丁基醚、乙醚、二甲基乙二醚或1,4-二氧六环;所述的芳烃类溶剂优选为甲苯;所述的酰胺类溶剂优选为N-甲基吡咯烷酮、N,N-二甲基甲酰胺、1,3-二甲基-3,4,5,6-四氢-2-嘧啶酮或N,N-二甲基乙酰胺;所述的亚砜类溶剂优选为二甲亚砜;较佳地,所述的溶剂为四氢呋喃、2-甲基四氢呋喃、甲基叔丁基醚、乙醚、二甲基乙二醚、1,4-二氧六环和甲苯中的一种或多种,例如四氢呋喃。And/or, when the hydrogenation reaction is carried out in the presence of a solvent; the solvent is one or more of ether solvents, aromatic hydrocarbon solvents, amide solvents, sulfoxide solvents and water; the The ether solvent is preferably tetrahydrofuran, 2-methyltetrahydrofuran, methyl tert-butyl ether, diethyl ether, dimethyl ethylene glycol or 1,4-dioxane; the aromatic hydrocarbon solvent is preferably toluene; the The amide solvent is preferably N-methylpyrrolidone, N,N-dimethylformamide, 1,3-dimethyl-3,4,5,6-tetrahydro-2-pyrimidinone or N,N- Dimethylacetamide; the sulfoxide solvent is preferably dimethyl sulfoxide; preferably, the solvent is tetrahydrofuran, 2-methyltetrahydrofuran, methyl tert-butyl ether, diethyl ether, dimethyl ethyl ether One or more of diether, 1,4-dioxane, and toluene, such as tetrahydrofuran. 8.一种如式C所示的环十二酮的制备方法,其包含如下步骤:8. a preparation method of cyclododecanone as shown in formula C, it comprises the steps: (1)按照如权利要求1~7中任一项所述的如式B所示的化合物的制备方法,制得所述的如式B所示的化合物;(1) According to the preparation method of the compound represented by the formula B according to any one of claims 1 to 7, the compound represented by the formula B is prepared; (2)在金属盐存在下,所述的如式B所示的化合物进行如下所示的重排反应得如式C所示的化合物;(2) in the presence of a metal salt, the compound shown in the formula B carries out the rearrangement reaction shown below to obtain the compound shown in the formula C;
Figure FDA0002993174900000051
Figure FDA0002993174900000051
9.如权利要求8所述的如式C所示的环十二酮的制备方法,所述的重排反应在无溶剂或有溶剂的存在下进行;9. the preparation method of cyclododecanone shown in formula C as claimed in claim 8, described rearrangement reaction is carried out in the presence of solvent-free or with solvent; 和/或,所述的金属盐为金属卤盐;And/or, the metal salt is a metal halide salt; 和/或,所述的金属盐与所述的如式B所示化合物的摩尔比为0.0001~0.99;And/or, the molar ratio of the metal salt to the compound represented by formula B is 0.0001-0.99; 和/或,所述的重排反应的反应温度为100~180℃;And/or, the reaction temperature of the rearrangement reaction is 100~180℃; 和/或,所述的重排反应的反应时间为4~6h。And/or, the reaction time of the rearrangement reaction is 4-6h. 10.如权利要求9所述的如式C所示的环十二酮的制备方法,所述的重排反应中,所述的金属盐与所述的如式B所示化合物的摩尔比为0.001~0.1,例如0.04、0.02或0.05;10. the preparation method of the cyclododecanone shown in formula C as claimed in claim 9, in the described rearrangement reaction, the mol ratio of described metal salt and described compound shown in formula B is 0.001~0.1, such as 0.04, 0.02 or 0.05; 和/或,所述的金属盐为LiCl、LiBr、LiI、NaCl、NaBr、NaI、KCl、KBr、KI、MgCl2、MgBr2、MgI2、MgBr2OEt2和MgI2OEt2中的一种或多种;例如LiBr、LiI、NaI、LiBr、MgBr、MgI2或MgBr2OEt2And/or, the metal salt is one of LiCl, LiBr, LiI, NaCl, NaBr, NaI, KCl, KBr, KI, MgCl 2 , MgBr 2 , MgI 2 , MgBr 2 OEt 2 and MgI 2 OEt 2 or more; such as LiBr, LiI, NaI, LiBr, MgBr, MgI 2 or MgBr 2 OEt 2 ; 和/或,所述的重排反应的反应温度为140~165℃;And/or, the reaction temperature of the rearrangement reaction is 140~165 ℃; 和/或,在二甘醇二甲醚存在下反应;较佳地,所述的如式B所示化合物与所述的二甘醇二甲醚的摩尔体积比为1~5mmol/L,例如2mmol/L。And/or, the reaction is carried out in the presence of diglyme; preferably, the molar volume ratio of the compound shown in formula B to the diglyme is 1 to 5 mmol/L, for example 2mmol/L.
CN202110321836.1A 2021-03-25 2021-03-25 Preparation method of cyclododecane oxide and cyclododecanone Pending CN115124491A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110321836.1A CN115124491A (en) 2021-03-25 2021-03-25 Preparation method of cyclododecane oxide and cyclododecanone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110321836.1A CN115124491A (en) 2021-03-25 2021-03-25 Preparation method of cyclododecane oxide and cyclododecanone

Publications (1)

Publication Number Publication Date
CN115124491A true CN115124491A (en) 2022-09-30

Family

ID=83373849

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110321836.1A Pending CN115124491A (en) 2021-03-25 2021-03-25 Preparation method of cyclododecane oxide and cyclododecanone

Country Status (1)

Country Link
CN (1) CN115124491A (en)

Similar Documents

Publication Publication Date Title
WO2016131371A1 (en) Method for preparing formamide compound
CN108774271A (en) A kind of chiral nitrogen nitrogen phosphine tridentate ligand and its application based on ferrocene frame having ferrocene frame
CN113563370B (en) Preparation method for preparing beta-boron-based ketone with alpha-position substituent by catalysis of chitosan loaded copper material
CN107011145A (en) A kind of method that utilization visible light catalytic prepares the derovatives of alkene 1,4 of 2 iodine penta 2
CN109942364A (en) A kind of olefin synthesis method using water as hydrogen source
WO2020057274A1 (en) Method for preparing substituted primary amine
CN108558635B (en) Preparation method of 3-arylpropynoic acids and 3-arylpropynoic acid ester compounds
CN103304393A (en) Synthetic method of benzil derivatives
CN101701066A (en) Polyether-supported N-heterocyclic carbene palladium compound and its preparation method and use
CN115124491A (en) Preparation method of cyclododecane oxide and cyclododecanone
CN106167459B (en) A method of synthesis alkenyl thiocyanates derivative
CN107746392A (en) A kind of preparation method of the oxazole alkyl compound containing caged scaffold
CN109939737B (en) Cobalt carbene catalysts, method for the production thereof, and use thereof for the catalytic hydrogenation of aldehyde and ketone compounds
CN103319296B (en) A kind of preparation method of tetramethyl biphenyl
CN106187656A (en) The method of magnesium auxiliary nickel catalysis polyfluoro aromatic hydrocarbons list arylation
CN103145769B (en) Bis-cyclometallated compound of heteronuclear ruthenium palladium and its preparation method and application
CN113651679B (en) Method for preparing beta-substituted ketone/alcohol by high-selectivity catalytic dehydrogenation coupling of secondary alcohol
CN102452911B (en) Method for converting C-N bond to C-C bond by allyl substitution reaction based on palladium catalysis
CN107400057B (en) The N- alkylated reaction of nickel catalysis prepares secondary amine or N '-alkyl hydrazine
CN105017109A (en) Method for compounding sulphone by directly conducting sulfonylation on alcohol
CN110003275A (en) A kind of synthetic method of 4,6- bis- (diphenylphosphine) compound phenazine
CN115894335B (en) Method for synthesizing 2-phenylindole compound by utilizing alkyne halogen and aniline compound
CN114805127B (en) Preparation method of 2-trifluoromethyl-1-tetralone compound
CN111302880B (en) Application of iron catalyst in reduction coupling reaction and preparation method of aromatic ring and heterocyclic derivative
CN113244957B (en) A kind of polycarbene iridium catalyst and its preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination